New Haven, Conn. —Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven have appointed Steven D. Gore, MD, an internationally known hematologist, as Director of Hematologic Malignancies at Smilow Cancer Hospital. Dr. Gore joins Yale from The Johns Hopkins University School of Medicine. He will begin his new appointment on November 1, 2013.
“Dr. Gore’s national leadership on clinical trials for patients with leukemia and meylodysplastic syndromes and focus on translational research will elevate our Hematology Program at Smilow Cancer Hospital at Yale-New Haven,” said Madhav V. Dhodapkar, MBBS, Chief of Hematology at Yale Cancer Center and Smilow Cancer Hospital. “I’m looking forward to having him join our team, and am confident he will bring new treatment opportunities for our patients.”
Currently, Dr. Gore is a Professor of Oncology at The Johns Hopkins School of Medicine and a Faculty Member in their Cell and Molecular Medicine Program. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Association for Cancer Research. Dr. Gore is a member of the Leukemia Core Committee and the Leukemia Correlative Science Committee of the Eastern Cooperative Oncology Group. He also Chairs the Hematologic Malignancies Committee of the Mayo Phase 2 Consortium.
Dr. Gore received his undergraduate degree from Yale College and his medical degree from Yale University. He completed his internship and residency at the University of Chicago Hospitals and Clinics and his fellowship in oncology at The Johns Hopkins University School of Medicine. He has authored more than 200 peer-reviewed articles and book chapters on hematologic malignancies and myelodysplastic syndromes.
Yale Cancer Center is one of a select network of 41 comprehensive cancer centers in the country designated by the National Cancer Institute. Bringing together the resources of Smilow Cancer Hospital at Yale-New Haven and Yale School of Medicine, its mission encompasses patient care, research, cancer prevention and control, community outreach and education.